Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Operating Margin (2020 - 2025)

Historic Operating Margin for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to 27.83%.

  • PROCEPT BioRobotics' Operating Margin rose 105900.0% to 27.83% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.85%, marking a year-over-year increase of 224200.0%. This contributed to the annual value of 43.04% for FY2024, which is 371200.0% up from last year.
  • According to the latest figures from Q3 2025, PROCEPT BioRobotics' Operating Margin is 27.83%, which was up 105900.0% from 28.02% recorded in Q2 2025.
  • PROCEPT BioRobotics' Operating Margin's 5-year high stood at 27.83% during Q3 2025, with a 5-year trough of 166.02% in Q4 2021.
  • For the 5-year period, PROCEPT BioRobotics' Operating Margin averaged around 87.81%, with its median value being 77.41% (2023).
  • As far as peak fluctuations go, PROCEPT BioRobotics' Operating Margin surged by 3733900bps in 2021, and later plummeted by -56700bps in 2023.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Operating Margin stood at 166.02% in 2021, then skyrocketed by 37bps to 105.31% in 2022, then skyrocketed by 36bps to 67.82% in 2023, then skyrocketed by 57bps to 28.89% in 2024, then increased by 4bps to 27.83% in 2025.
  • Its Operating Margin was 27.83% in Q3 2025, compared to 28.02% in Q2 2025 and 39.67% in Q1 2025.